Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
6.01 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 37.233 | 85.388 | 43.994 | 57.206 | 87.131 | 51.23 | 63.902 | 65.675 | 16.577 | 21.726 | 30.699 | 8.859 | 10.511 | 6.837 |
| Short Term Investments
| 210.953 | 284.522 | 205.238 | 186.796 | 299.518 | 284.006 | 244.828 | 157.994 | 193.507 | 123.479 | 60.065 | 92.621 | 33.251 | 16.492 |
| Cash and Short Term Investments
| 248.186 | 369.91 | 249.232 | 244.002 | 386.649 | 335.236 | 308.73 | 223.669 | 210.084 | 145.205 | 90.764 | 101.48 | 43.762 | 23.329 |
| Net Receivables
| 6.646 | 39.618 | 49.036 | 60.831 | 23.492 | 51.313 | 67.205 | 10.614 | 12.841 | 15.722 | 4.494 | 1.592 | 2.942 | 0.261 |
| Inventory
| 0 | 0 | 0 | -37.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 45.02 | 13.263 | 13.445 | 14.188 | 40.351 | 30.598 | 8.908 | 7.072 | 18.462 | 17.981 | 14.311 | 3.282 | 0.604 | 1.509 |
| Total Current Assets
| 299.852 | 422.791 | 311.713 | 319.021 | 436.837 | 401.848 | 380.389 | 237.819 | 232.156 | 170.641 | 107.975 | 104.713 | 47.308 | 25.099 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 73.346 | 34.713 | 29.748 | 10.654 | 15.616 | 10.927 | 8.374 | 8.049 | 8.004 | 5.886 | 1.803 | 1.121 | 0.611 | 0.534 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | -5.18 | -2.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 29.285 | 108.416 | 32.634 | 65.013 | 16.389 | 70.038 | 32.119 | 64.238 | 41.003 | 10.703 | 1.656 | 0 |
| Tax Assets
| 0 | 0 | 5.18 | 2.07 | 0.345 | 11.341 | 8.375 | 10.123 | 8.39 | 4.64 | 4.198 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.454 | 4.771 | 4.664 | 0.7 | 0.7 | 0.7 | 0.7 | 0.608 | 0.608 | 0.608 | 0.436 | 0.436 | 2.587 | 0.463 |
| Total Non-Current Assets
| 76.8 | 39.484 | 63.697 | 119.77 | 49.295 | 87.981 | 33.838 | 88.818 | 49.121 | 75.372 | 47.44 | 12.26 | 4.854 | 0.997 |
| Total Assets
| 376.652 | 462.275 | 375.41 | 438.791 | 486.132 | 489.829 | 414.227 | 326.637 | 281.277 | 246.013 | 155.415 | 116.973 | 52.162 | 26.096 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 8.002 | 4.097 | 6 | 9.54 | 5.737 | 6.689 | 4.745 | 3.714 | 3.377 | 1.543 | 1.874 | 1.481 | 1.851 | 0.566 |
| Short Term Debt
| 3.048 | 5.275 | 5.782 | 8.406 | 8.522 | 0 | 0 | 0.079 | 0.073 | 0.069 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 1.388 | 9.298 | 0 | 1.199 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.298 | 0 | 1.199 | 0 | 0.01 | 0.017 | 0 |
| Other Current Liabilities
| 46.485 | 53.415 | 18.045 | 18.226 | 9.898 | 15.92 | 9.892 | 7.891 | 4.439 | 3.893 | 2.872 | 3.035 | 3.866 | 1.583 |
| Total Current Liabilities
| 57.535 | 62.787 | 29.827 | 36.172 | 24.157 | 22.609 | 16.025 | 20.982 | 7.889 | 6.704 | 4.746 | 4.526 | 5.734 | 2.149 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 53.943 | 21.238 | 22.372 | 1.126 | 5.317 | 0.2 | 0.293 | 0.379 | 0.458 | 0.529 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | -5.18 | -2.07 | 0.691 | -0.318 | -0.457 | 0.015 | 0.207 | 0.462 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 5.18 | 2.07 | 0.788 | 1.746 | 1.792 | 1.175 | 0.745 | 0.448 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 136.36 | 161.515 | 1.877 | 2.064 | 1.078 | 4.528 | 4.23 | 3.6 | 2.994 | 2.623 | 2.015 | 1.979 | 2.499 | 155.908 |
| Total Non-Current Liabilities
| 190.303 | 182.753 | 24.249 | 3.19 | 6.395 | 4.728 | 4.523 | 3.979 | 3.452 | 3.152 | 2.015 | 1.979 | 2.499 | 155.908 |
| Total Liabilities
| 247.838 | 245.54 | 54.076 | 39.362 | 30.552 | 27.337 | 20.548 | 24.961 | 11.341 | 9.856 | 6.761 | 6.505 | 8.233 | 158.057 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 1.423 | 1.506 | 1.479 | 1.628 | 1.628 | 0.762 | 0.159 | 0.163 | 0.202 | 116.973 | 159.282 | 0 |
| Common Stock
| 0.212 | 0.211 | 0.208 | 0.202 | 0.201 | 0.197 | 0.194 | 0.191 | 0.19 | 0.187 | 0.188 | 0.181 | 0.013 | 0.053 |
| Retained Earnings
| -323.04 | -206.995 | -73.179 | 48.576 | 127.572 | 163.74 | 117.357 | 45.356 | 27.646 | 5.98 | -73.012 | -107.45 | -115.374 | -132.004 |
| Accumulated Other Comprehensive Income/Loss
| 0.302 | -1.174 | -3.724 | -0.382 | 0.844 | 0.146 | -0.398 | -0.112 | 0.019 | 0.033 | -0.1 | -0.002 | 0.01 | -0.001 |
| Other Total Stockholders Equity
| 451.34 | 424.693 | 398.029 | 351.033 | 326.963 | 298.409 | 276.526 | 256.241 | 242.081 | 229.957 | 221.174 | 217.739 | -0.002 | 153.913 |
| Total Shareholders Equity
| 128.814 | 216.735 | 321.334 | 399.429 | 455.58 | 462.492 | 393.679 | 301.676 | 269.936 | 236.157 | 148.654 | 110.468 | 43.929 | -131.961 |
| Total Equity
| 128.814 | 216.735 | 321.334 | 399.429 | 455.58 | 462.492 | 393.679 | 301.676 | 269.936 | 236.157 | 148.654 | 110.468 | 43.929 | -131.961 |
| Total Liabilities & Shareholders Equity
| 376.652 | 462.275 | 375.41 | 438.791 | 486.132 | 489.829 | 414.227 | 326.637 | 281.277 | 246.013 | 155.415 | 116.973 | 52.162 | 26.096 |